HEALTH chiefs have unveiled “significant”; changes to the childhood immunisation schedule following a surge in a killer infection.
The age at which children get the , which protects against , and rubella has been brought forward from three years old to just 18 months.
It comes after the UK has seen a , while .
Globally, rates of the lethalhad doubled in the past year alone.
Two doses offer up to 99 per cent protection against measles, mumps and rubella, which can lead to deadly , and problems during .
Officals from the UK Health Security Agency (UKHSA) hope the move with “improve uptake and provide earlier protection”;.
There are four other changes to the jab programme which will“optimise the overall protection of children in the UK”;, they added.
One of the main tweaks is the introduction of a new fourth dose of the 6-in-1 vaccine, given at 18 months.
This jab protects against diphtheria, tetanus, whooping cough (also known as pertussis), polio, hepatitis B and Hib – short for haemophilus influenzae type b.
Hib is a type of bacteria that can cause life-threatening infections like meningitis and sepsis.
The change will apply to children turning one on or after July 1, 2025, who will then be offered the extra dose when they hit 18 months.
Health officials say the update is needed because the current Hib/Men C vaccine, called Menitorix, which is offered at the one-year mark, is being discontinued due to supply issues.
Despite this, the 12-month appointment will still include the first dose of the MMR vaccine. along with booster shots for meningitis B and pneumococcal disease.
Other changesinvolve the second dose of the meningitis B vaccine being given earlier, at 12 weeks instead of 16. This follows a recent study showing that earlier protection could be more effective.
To balance this out and avoid too many jabs at one time, the first dose of the pneumococcal vaccine is being moved from 12 weeks to 16 weeks.
From January 1, 2026, children turning 18 months will be offered their second MMR jab much earlier than before – at 18 months instead of waiting until three years and four months.
However, kids who are already between 18 months and three years four months on January 1, 2026, will stay on the current schedule and get their second MMR dose at the usual time.
Latest NHS Digital data shows that in some parts of England, up to three in ten children haven’t had both MMR jabs by the time they turn five.
But the figure needs to be above 90 per cent to stop outbreaks, public health guidance says.
mostly produces flu-like symptoms including a fever, a cough, a cold, and a blotchy rash that is usually not itchy.
But in some cases, it can travel to other parts of the body, like the lungs or brain, and cause serious illness.
Complications include,, blindness, seizures, and death.
It is transmitted through direct contact with airborne droplets that spread when a person breathes, coughs, or sneezes.
It’s very unlikely to be measles if you’ve had both MMR vaccine doses or had measles before.
TheMMR vaccine is free to everyone on the NHS and is available from GP surgeries.
‘Will save the lives of more very young babies’
Professor Azeem Majeed, from Imperial College London, told GP magazine Pulse: “The changes to the NHS childhood vaccination programme have important implications for general practices and parents of children in England.
“For general practices, the guidance requires significant adjustments to vaccination schedules, increased administrative efforts, and proactive communication to ensure compliance and maintain high uptake.
“For parents, the changes mean adapting to a new 18-month appointment, understanding the revised schedule based on their child’s birth date, and ensuring timely vaccinations.”;
Dr Julie Yates, from UKHSA, added: “Following a review of the latest evidence, the Joint Committee on Vaccination and Immunisation (JCVI)recommended a number of changes to optimise the Childhood Immunisation programme and increase overall protection of children in the UK.
“With the UK close to seeing an end to Meningitis C circulating, JCVI advised that a vaccination is no longer required for infants due to the excellent population protection provided by the adolescent Meningitis ACWY programme.
“Other changes, such as the bringing forward of the Meningitis B vaccine are based on evidence that will save the lives of more very young babies.”;
